A clinical road map for single-cell omics
Despite initial forays into clinical settings, single-cell technologies do not yet routinely inform medical decision-making. Here, we identify and categorize barriers hindering the clinical deployment of single-cell omics. We articulate a framework to identify patient subpopulations that stand to benefit from such biomarkers and outline the requirements to derive actionable clinical readouts.